| Factor Information | |
|---|---|
| Data ID | 2317 |
| Factor | fetal echocardiography (echoCG) |
| Description | We hypothesized that fetal echocardiography (echoCG) is an accurate diagnostic tool reflecting well postnatal echoCG findings and outcomes. |
| Biomarker | NA |
| Classification | A2 (clinical factor - diagnosis) |
| Association | |
|---|---|
| Application | diagnosis |
| Objective | We hypothesized that fetal echocardiography (echoCG) is an accurate diagnostic tool reflecting well postnatal echoCG findings and outcomes. |
| Conclusion | There is a recent increase in abnormal cardiac findings of obstetric ultrasonography screenings that indicate fetal echoCG. Fetal echoCG is still a good, accurate diagnostic method for congenital heart disease. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 597 |
| CHD Type | isolated CHD |
| CHD Subtype | VSD/TOF/DORV/CoA/AVSD/TGA/SV/EA/PA/IVS/HLHS/IAA/other |
| Reference | |
|---|---|
| PMID | 23323122 |
| Year | 2012 |
| Title | Recent Trends in Indications of Fetal Echocardiography and Postnatal Outcomes in Fetuses Diagnosed as Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | pregnant women and fetuses | |
| Source | Database | |
| Region | Seoul, Korea | |
| Method | We reviewed the medical records of 290 pregnant women, including 313 fetuses, who were examined by fetal echoCG at the Seoul National University Children’s Hospital from January 2008 through April 2011. | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | N/A(Treatment) | N/A(Control) |
| Number | 290 pregnant women, including 313 fetuses | N/A |
| Age | gestational age: 26.2±5.2 weeks; mothers: 31.7±3.8 years | N/A |
| Gender (Male: Female) | pregnant women: female | N/A |
| Marker Level | N/A | N/A |
